NCLEX
Price
$27.45
Change
+$1.99 (+7.82%)
Updated
Apr 9 closing price
Net Assets
438.17M
VSGAX
Price
$85.41
Change
+$8.10 (+10.48%)
Updated
Apr 9 closing price
Net Assets
33.7B
Ad is loading...

NCLEX vs VSGAX

Header iconNCLEX vs VSGAX Comparison
Open Charts NCLEX vs VSGAXBanner chart's image
Nicholas Limited Edition I
Price$27.45
Change+$1.99 (+7.82%)
VolumeN/A
Net Assets438.17M
Vanguard Small Cap Growth Index Admiral
Price$85.41
Change+$8.10 (+10.48%)
VolumeN/A
Net Assets33.7B
NCLEX vs VSGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NCLEX vs. VSGAX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NCLEX is a Buy and VSGAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSGAX has more cash in the bank: 33.7B vs. NCLEX (438M). VSGAX pays higher dividends than NCLEX: VSGAX (0.60) vs NCLEX (0.00). NCLEX was incepted earlier than VSGAX: NCLEX (38 years) vs VSGAX (14 years). NCLEX (0.85) is less costly to investors than VSGAX (0.07). VSGAX is a more actively managed with annual turnover of: 19.00 vs. NCLEX (12.81). VSGAX has a lower initial minimum investment than NCLEX: VSGAX (3000) vs NCLEX (100000). NCLEX annual gain was more profitable for investors over the last year : -11.81 vs. VSGAX (-14.20). VSGAX return over 5 years is better than : 36.60 vs. NCLEX (8.20).
NCLEXVSGAXNCLEX / VSGAX
Total Expense Ratio0.850.071,214%
Annual Report Gross Expense Ratio0.850.071,214%
Fund Existence38 years14 years-
Gain YTD-16.057-21.42575%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets438M33.7B1%
Annual Yield % from dividends0.000.60-
Returns for 1 year-11.81-14.2083%
Returns for 3 years-14.71-7.65192%
Returns for 5 years8.2036.6022%
Returns for 10 years-5.1466.80-8%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAVPX13.06N/A
N/A
Lord Abbett Fundamental Equity P
FACEX12.06N/A
N/A
Frost Growth Equity Investor
NRFAX10.90N/A
N/A
Natixis AEW Global Focused Real Estate A
JGAQX32.75N/A
N/A
JPMorgan Value Advantage R2
JEQSX32.44N/A
N/A
Johnson Equity Income S